Select Page

Intensive Care Unit (ICU)

For information on ICU clinical trials, please contact Maxime Boutin-Caron.
 

Current Recruiting Studies

Aneurysmal SubArachnoid Hemorrhage – Red Blood Cell Transfusion And Outcome (SAHaRA): A Randomized Controlled Trial

From clinicaltrials.gov:

The SAHaRA trial will clarify the role of treating anemia with Red Blood Cell (RBC) transfusion in a unique and vulnerable patient population, and determine whether that impacts on functional outcomes and mortality. It will guide best practice standards and clarify the optimal RBC transfusion strategy in patients with aSAH.

More information

CT-Perfusion for neurological diagnostic evaluation: a prospective Canadian multicenter diagnostic test study

From clinicaltrials.gov:

For the purpose of organ donation after neurological determination of death (NDD), death must be declared using a set of standardized clinical criteria. When a full clinical evaluation cannot be completed, additional neuroimaging ancillary testing is required. The ideal ancillary test for NDD would demonstrate no cerebral blood flow, be free of false-positive and false negative results, rapid, safe, readily available, non-invasive, and inexpensive. No current ancillary test for NDD meets these criteria. Computed tomography (CT) perfusion has the characteristics of an ideal test for NDD, but has not been evaluated for routine clinical use for NDD.

The overarching goal of this project is to improve the NDD process by establishing CT-perfusion as the ideal ancillary test. A large prospective Canadian multi-centre diagnostic cohort study will be conducted to validate CT-perfusion for the neurological determination of death.

More information